Lupin Archives - Page 19 of 36

Lupin Outlook for the Week (Jan 01, 2018 – Jan 05, 2018)

adminDecember 29, 2017December 7, 2020

by adminDecember 29, 2017December 7, 20200518

EquityPandit’s Outlook for Lupin for the week ( Jan 01, 2018 – Jan 05, 2018) : LUPIN: Lupin closed the week on positive note gaining around 1.50%....

Lupin gets USFDA nod for Calcipotriene Topical Solution

adminDecember 29, 2017

by adminDecember 29, 20170769

Lupin has received final approval for Calcipotriene Topical Solution, 0.005% (Scalp Solution), from USFDA. The company has received approval to market a generic version of Dovonex...

LUPIN

Lupin Outlook for the Week (Dec 26, 2017 – Dec 29, 2017)

adminDecember 22, 2017December 7, 2020

by adminDecember 22, 2017December 7, 20200525

EquityPandit’s Outlook for Lupin for the week (Dec 26, 2017 – Dec 29, 2017) : LUPIN: Lupin closed the week on positive note gaining...

LUPIN

Lupin Outlook for the Week (Dec 18, 2017 – Dec 22, 2017)

adminDecember 15, 2017December 7, 2020

by adminDecember 15, 2017December 7, 20200523

EquityPandit’s Outlook for Lupin for the week (Dec 18, 2017 – Dec 22, 2017) : LUPIN: Lupin closed the week on positive note gaining...

Lupin receives approval for Tydemy from USFDA

adminDecember 14, 2017

by adminDecember 14, 20170856

Lupin has received approval from the US health regulator, for Tydemy drug that is used to prevent pregnancy. The company has received final approval for its Tydemy (Drospirenone, Ethinyl...

LUPIN